FDA adds warning to Moderna and Pfizer vaccine for rare heart inflammation!

The US’s Food and Drug Administration (FDA) has added a warning to the covid vaccine for Moderna and Pfizer regarding the rare heart inflammation. On Friday, FDA added the warning for the recipients of the said two vaccine.

The administration also presented fact sheets for Moderna and Pfizer vaccines, which indicate a rare heart condition which causes heart inflammation. For each vaccine, the revised fact sheets have included warning about Myocarditis (inflammation of heart muscle) and Pericarditis (inflammation of the tissue surrounding the heart).

As advised by FDA, vaccine recipients should seek immediate medical attention if they experience “chest pain, shortness of breath, or feelings of having a fast-beating, fluttering, or pounding heart after vaccination.”

FDA said, “This update follows an extensive review of information and the discussion by CDC’s Advisory Committee on Immunization Practices meeting on Wednesday. The data presented at this meeting reinforced the FDA’s decision to revise the fact sheets and further informed the specific revisions.”

As per the updated warning, the symptoms of these conditions may appear within a few days after receiving the shot. However, the medical experts still claim that the benefits of these vaccines outweighs the side effects.

Janet Woodcock, the acting FDA commissioner, said in a statement, “The risk of myocarditis and pericarditis appears to be very low given the number of vaccine doses that have been administered.” She added, “The benefits of Covid-19 vaccination continue to outweigh the risks, given the risk of Covid-19 diseases and related, potentially severe, complications,”

Recently, cases of rare heart inflammation were reported among those vaccinated citizens, who received either Moderna of Pfizer vaccine for Covid. According to the reports, there have been more than 1200 cases of myocarditis and pericarditis. The rare heart condition is observed in the recipients of the said vaccines, who fall in the category of 30 years old and below. As per the Centers for Disease Control and Prevention’s “CDC) data, about 300 million shots had been administered as of June 11, out of which, only 12.6 heart inflammation cases per million doses were found (for both vaccines combined).

Currently, both CDC and FDA are monitoring the reports of these adverse outcomes of Covid vaccines and they will follow up to assess longer-term outcomes.


Please enter your comment!
Please enter your name here

Read More

UAE: Dubai Police Museum records 4,476 visits in 2022, says reports

United Arab Emirates: Dubai Police Museum has recently updated that around 4,476 visitors were welcomed to the premises in 2022. The Dubai Police Department has reported a significant increase in the past year. 

Egypt: NMEC celebrates advent of holy month of Ramadan through heritage art workshops

Middle East, Egypt: The Ministry of Tourism and Antiquities has recently shared an update regarding the celebration event held by the National Museum of Egyptian Civilization (NMEC) on the advent of the holy month of Ramadan under the title "In the spirit of Ramadan in celebration of the advent of the month of Ramadan."

DUBAI EXPO 2020: Authorities extends pavilion visiting hours

Dubai EXPO 2020 authorities have stated that the opening hours for all of the pavilions will be extended till 11 pm, as the EXPO is on its verge to end.


10000 meal boxes distributed to motorists by Dubai Customs during Ramadan

For two years in a row, efforts taken by Dubai Customs (DC) voluntarily continue throughout the holy month of Ramadan with the distribution of meals to motorists so they can break their fast during sunset and don't drive in Overspeed to reach home early. This is under the DC's yearly "Blessed Days" Campaign.

Airfares from Dubai estimated to rise by 80% in June, July

Airfares from Dubai to major locations around the around the Far East, Europe and South Asia could rise by 80% during the forthcoming weeks as demand outruns supply.

St Kitts and Nevis: CIU Head Michael Martin introduces Limited Time Offer, attracts elite investors

Michael Martin - the Head of the CIU Unit, has been taking every necessary step to transform the programme into a suitable choice for potential investors and High Net-Worth Individuals (HNWIs).